Virtual alcohol use disorder treatment company Ria Health completed an $18 million Series A funding round led by SV Health Investors.
Other participants in the round include SV limited partners, BPEA Private Equity and previous investor SOSV.
WHAT IT DOES
Ria provides virtual care for alcohol use disorder, including medication-assisted treatment like naltrexone, acamprosate and gabapentin that...
Digital mental health company Cerebral is launching a new program aimed at treating opioid use disorder.
The startup said users will work with "licensed prescribers" to build treatment plans, including ones employing medications like Suboxone, which was developed to manage withdrawals and prevent overdoses. Members who join the program can also access virtual counseling sessions.
The program is...
Quit Genius, a digital addiction-recovery program, has extended its platform to support alcohol and opioid addictions.
The program is designed for enterprise and health plan customers in the U.S. to help their employees recover from addiction.
Fees are paid for by the user’s employer or health plan. Employers are charged an annual fee for each participant that actually enrolls in the program.
The...
Yesterday morning addiction focused digital therapeutic Quit Genius scored $11 million in Series A funding. Octopus Ventures led the round with participation from Y Combinator, Startup Health and Triple Point Ventures.
This brings the company's total funding pot to $13.5 million.
WHAT THEY DO
The company is geared at treating individuals with tobacco-, opioid- and alcohol-use disorder through...
Boston-based addiction recovery platform DynamiCare Health has collected $4.1 million in seed funding from Hyperplane Venture Capital, former US Representative Patrick J. Kennedy and other unnamed investors.
What they do
Founded in 2016, DynamiCare Health has built a platform supports users’ substance use disorder recovery with a number of smartphone-based features. These include random breath...
Yesterday morning addiction-focused telemedicine company Workit Health announced a new Series A funding round led by Blue Cross Blue Shield Venture Partners for an undisclosed amount. Other funders include Endeavor Catalyst, Montage Ventures, Lux Capital, Wakestream Ventures, Invest Detroit and RRE Ventures.
This marks the second funding round for the Californian startup. Originally founded in...
DyAnsys, a medical device company specializing in the autonomic nervous system, announced this week that it has received FDA approval for a wearable auricular neurostimulation device designed to treat symptoms of opioid withdrawal.
The device, called Drug Relief, is now available to providers in the US, and is distributed in the EU by the DyAnsys’ European branch.
"This device offers hope to...
Members of a smoking cessation Facebook group were 2.5 times more successful in quitting than controls over three-month, according to a recent study published in Addiction. However, after a year, those in the intervention group actually had lower rates of cessation than the control group.
"We found that we could reach a hard-to-reach population, have short-term abstinence, and also have...
One of the biggest hurdles to addressing the opioid crisis in the US is knowing what alternative, non-opioid medications to prescribe for the treatment of chronic pain. Physicians struggle with a complex, patchwork system of state guidelines and regulations that vary with each particular state.
Enter Avella, a Phoenix-based specialty pharmacy that has just launched a new mobile app aimed at...
